Security readout for executives and security teams
Plain-English summary
CVE-2018-4845 affects Siemens Healthineers RAPIDLab and RAPIDPoint blood gas analyzer systems. A user with credentials to the Remote View feature could gain higher privileges and compromise confidentiality, integrity, or availability. This matters most in clinical environments where device reliability and patient-care workflows depend on these systems.
Executive priority
Treat this as a high-priority medical device exposure review, not an internet-wide emergency. The main urgency is confirming whether clinical analyzer systems are affected, whether Remote View is accessible, and whether Siemens mitigations have been applied.
Technical view
The issue is classified as CWE-284, improper access control. A local or remote credentialed attacker with Remote View access may elevate privileges on affected RAPIDLab 1200, RAPIDPoint 400, and RAPIDPoint 500 configurations. The source bundle provides no CVSS score. Siemens confirmed the issue and references mitigations in SSA-755010.
Likely exposure
Exposure is likely limited to healthcare environments operating affected Siemens Healthineers RAPIDLab or RAPIDPoint systems, especially where Remote View is enabled or reachable by credentialed users. The affected matrix varies by product version and Informatics product usage.
Exploitation context
The CVE states no special skills or user interaction are required, but the attacker needs local or remote credentialed access to Remote View. At advisory publication, Siemens reported no known public exploitation. The bundle does not indicate CISA KEV listing or current active exploitation.
Researcher notes
Evidence supports privilege escalation through Remote View with credentialed access. The source bundle does not provide CVSS vectors, exploit details, or exact remediation text. Avoid overstating exploit maturity; use Siemens SSA-755010 and CVE records as the authoritative references.
Mitigation direction
- Review Siemens Healthineers SSA-755010 for product-specific mitigations.
- Apply Siemens-confirmed mitigations for each affected system configuration.
- Restrict Remote View access to authorized operational users only.
- Review accounts with local or remote Remote View access.
- Check Siemens guidance before assuming a patch path.
Validation and detection
- Inventory RAPIDLab 1200, RAPIDPoint 400, and RAPIDPoint 500 systems.
- Record software versions and Informatics product usage for each system.
- Determine whether Remote View is enabled or remotely accessible.
- Compare each device against the affected version matrix.
- Confirm Siemens SSA-755010 mitigation status for each affected device.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-284: Authorization and privilege behavior lookup
Authorization weaknesses can support privilege escalation and valid-account review, depending on exploit path. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2018-4845 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://cert-portal.siemens.com/productcert/pdf/ssa-755010.pdfCVE reference · x_refsource_CONFIRM
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Access Control
Improper Access Control represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.